ambossIconambossIcon

Herpes virus infections

Last updated: September 19, 2024

Summarytoggle arrow icon

Human herpes viruses (HHV) are a large family of DNA viruses that remain dormant in a host following primary infection. An overview of the eight subtypes known to cause various diseases (ranging from asymptomatic to fatal disease courses) in humans is provided below. The specific conditions caused by the various HHVs are discussed in separate articles. Follow the links provided in the overview table below.

Icon of a lock

Register or log in , in order to read the full article.

Overviewtoggle arrow icon

Human herpes viruses (HHV) are members of a large family of DNA viruses, Herpesviridae, that infect humans. Human herpes viruses are classified into three main groups: [1]

Overview of human herpes viruses
Human herpes virus Subtypes Seroprevalence Mode of transmission Characteristics Disease Management
HHV-1 Herpes simplex virus 1 (HSV-1)
  • ≥ 50% in adults [2]
  • Saliva
  • Respiratory secretions
  • Antivirals may be indicated (see “Acyclovir.”)
HHV-2 Herpes simplex virus 2 (HSV-2)
  • 10–20% in adults [2]
HHV-3 Varicella zoster virus (VZV)
  • Up to 90% [3]
HHV-4 Epstein-Barr virus (EBV)
  • 65% in children, teens, and young adults between 6 and 19 years old [4]
  • Oncogenic potential: can immortalize and transform host B cells
  • Uses CD21 receptor to cause infection in B cells
  • Symptomatic therapy
  • Avoid physical activity that may trigger splenic rupture (e.g., contact sports) for at least 3 weeks
HHV-5 Cytomegalovirus (CMV)
  • ∼ 50% in the US [5]
  • Congenital
  • Sexual intercourse
  • Transfusions, transplants
  • Saliva
  • Urine
HHV-6
  • ∼ 90% in the US [7]
  • Saliva
  • Virus spreads early. [8][9]
  • Reactivation of latent virus or reinfection may occur later in life (especially if individuals become immunocompromised).
HHV-7
HHV-8 Kaposi's sarcoma-associated virus (KSHV)
  • Sexual intercourse
  • Has oncogenic potential
  • Infects endothelial cells causing malignant, multifocal, highly vascularized tumor
  • Treatment of the underlying disease (e.g., antiretroviral treatment in patients with HIV)

Icon of a lock

Register or log in , in order to read the full article.

Start your trial, and get 5 days of unlimited access to over 1,100 medical articles and 5,000 USMLE and NBME exam-style questions.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer